DELTEX MEDICAL GROUP PLC Financials Deltex Medical Group plc
Equities
DEMG
GB0059337583
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.135 GBX | 0.00% |
|
+8.00% | -6.90% |
| Apr. 02 | EARNINGS: AdvancedAdvT hails "good progress" after Capita deal | AN |
| Mar. 28 | Earnings Flash (DEMG.L) DELTEX MEDICAL GROUP Posts FY23 Revenue GBP1.8M | MT |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 4.434 | 7.284 | 8.082 | 8.335 | 6.991 | 2.678 |
| Enterprise Value (EV) 1 | 5.827 | 7.988 | 8.696 | 9.926 | 8.753 | 3.894 |
| P/E ratio | -3.36 x | -45 x | -9.39 x | -8.57 x | -5.99 x | -1.34 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 0.89 x | 1.71 x | 3.37 x | 3.69 x | 2.82 x | 1.51 x |
| EV / Revenue | 1.18 x | 1.88 x | 3.63 x | 4.39 x | 3.53 x | 2.19 x |
| EV / EBITDA | -7.71 x | 39.2 x | -15.2 x | -12.7 x | -9.64 x | -6.23 x |
| EV / FCF | -7.77 x | 16.8 x | -15.4 x | -13.3 x | -8.22 x | -3.67 x |
| FCF Yield | -12.9% | 5.95% | -6.48% | -7.52% | -12.2% | -27.2% |
| Price to Book | 1.74 x | 2.63 x | 2.92 x | 4.11 x | 2.98 x | 0.81 x |
| Nbr of stocks (in thousands) | 492,663 | 520,273 | 577,291 | 584,944 | 699,064 | 1,846,653 |
| Reference price 2 | 0.009000 | 0.0140 | 0.0140 | 0.0142 | 0.0100 | 0.001450 |
| Announcement Date | 4/26/19 | 6/17/20 | 6/30/21 | 4/11/22 | 3/30/23 | 4/8/24 |
1GBP in Million2GBP
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 4.955 | 4.256 | 2.398 | 2.259 | 2.482 | 1.776 |
| EBITDA 1 | -0.756 | 0.204 | -0.571 | -0.779 | -0.908 | -0.625 |
| EBIT 1 | -0.943 | 0.103 | -0.626 | -0.805 | -0.947 | -0.686 |
| Operating Margin | -19.03% | 2.42% | -26.11% | -35.64% | -38.15% | -38.63% |
| Earnings before Tax (EBT) 1 | -1.338 | -0.21 | -0.794 | -0.978 | -1.146 | -1.282 |
| Net income 1 | -1.264 | -0.159 | -0.785 | -0.966 | -1.145 | -1.282 |
| Net margin | -25.51% | -3.74% | -32.74% | -42.76% | -46.13% | -72.18% |
| EPS 2 | -0.002681 | -0.000311 | -0.001491 | -0.001663 | -0.001670 | -0.001085 |
| Free Cash Flow 1 | -0.7499 | 0.4754 | -0.5638 | -0.7462 | -1.065 | -1.06 |
| FCF margin | -15.13% | 11.17% | -23.51% | -33.03% | -42.92% | -59.71% |
| FCF Conversion (EBITDA) | - | 233.03% | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 4/26/19 | 6/17/20 | 6/30/21 | 4/11/22 | 3/30/23 | 4/8/24 |
1GBP in Million2GBP
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 1.39 | 0.7 | 0.61 | 1.59 | 1.76 | 1.22 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | -1.843 x | 3.451 x | -1.075 x | -2.042 x | -1.941 x | -1.946 x |
| Free Cash Flow 1 | -0.75 | 0.48 | -0.56 | -0.75 | -1.07 | -1.06 |
| ROE (net income / shareholders' equity) | -68.1% | -6.31% | -29.6% | -42.5% | -55.4% | -47.7% |
| ROA (Net income/ Total Assets) | -9.56% | 1% | -6.51% | -9.21% | -10.2% | -7.18% |
| Assets 1 | 13.22 | -15.88 | 12.07 | 10.49 | 11.19 | 17.86 |
| Book Value Per Share 2 | 0.0100 | 0.0100 | 0 | 0 | 0 | 0 |
| Cash Flow per Share 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capex 1 | 0.02 | 0.01 | 0.01 | 0.02 | 0.07 | 0.01 |
| Capex / Sales | 0.36% | 0.23% | 0.25% | 1.02% | 2.82% | 0.51% |
| Announcement Date | 4/26/19 | 6/17/20 | 6/30/21 | 4/11/22 | 3/30/23 | 4/8/24 |
1GBP in Million2GBP
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Chiffre d''affaires - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -6.90% | 3.19M | |
| +4.55% | 3.48B | |
| -12.80% | 156M | |
| -15.69% | 81.85M | |
| +30.43% | 59.71M |
- Stock Market
- Equities
- DEMG Stock
- Financials Deltex Medical Group plc
